mol # 79020molpharm.aspetjournals.org/content/suppl/2012/06/... · k.varghese, geetha b. kumar,...
TRANSCRIPT
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 1: HPLC profiles of CNSE (A), Cardol-Cardanol mixture (B) and
Anacardic acid mixture (C) using C-18 , reverse phase column, PDA and acetonitrile/ H2O / acetic acid
(72:18:10) as mobile phase at 245 nm. Anacardic acid mixture shows 3 major peaks for the unsaturated
forms of the material and a 4th near negligible peak for the saturated form.
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 2: Mass Spectrometry profiles. The masses (m/e) of the three major
HPLC molecular peaks, MH+ corresponds to 343 for the triene (A), 345 for the diene (B) and 347 for the
monoene (C) forms of anacardic acid.
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 3A: 1H NMR spectra for anacardic acid (triene), recorded on a Bruker
(Wissembourg, France) AM 500 spectrometer (500 MHz, for 1H NMR) using tetramethylsilane (TMS) as
a standard. Deuterated trichloromethane (CDCl3) solvent was used for all the samples. Chemical shift and
J are given in δ and Hz, respectively. The following NMR shifts corresponds to: 7.3 (C4, t, J=7.9Hz, 1H)-
aromatic proton, 6.87 (C5, d, J=8.3 Hz, 1H)-aromatic proton, 6.72 (C3, d, J=7.4, 1H)-aromatic proton,
4.97-5.7 (C15, C14, C12, C11, C10, C9, C8, m, 7H)-alkene protons, 2.98 (C7, t, 2H)-methylene protons
near alkene, 2.8 (C10, C13, q, 4H)-Skip methylene,2.0 (C1, q, 2H)- Benzyl proton, 1.3 (C6, C5, C4,
C3,C2, m )-methylene protons.
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 3B: 1H NMR spectra for anacardic acid (diene). The following NMR
shifts corresponds to: 7.3 (C4, t, J=7.9Hz, 1H)-aromatic proton, 6.87 (C5, d, J=8.3 Hz, 1H)-aromatic
proton, 6.72 (C3, d, J=7.4, 1H)-aromatic proton, 5.3 (C12, C11, C9, C8, m, 4H)-alkene protons, 3.0 (C7,
t, 2H)-methylene proton near alkene, 2.77 (C10, q, 2H)-Skip methylene, 1.6 (C1, t, 2H)- Benzyl proton,
1.3 (C6, C5, C4, C3, C2, m)-methylene protons, 0.9 (C15, t, 3H)- methyl protons.
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 3C: 1H NMR spectra for anacardic acid (monoene). The following
NMR shifts corresponds to: 7.3 (C4, t, J=7.9Hz, 1H)-aromatic proton, 6.87 (C5, d, J=8.3 Hz, 1H)-
aromatic proton, 6.72 (C3, d, J=7.4, 1H)-aromatic proton, 5.3 (C9, C8, t, 2H)-alkene protons, 3.0 (C7, t,
2H)-methylene proton near alkene, 1.6 (C1, t, 2H)- Benzyl protons, 1.2 (C2, C3, C4, C5, C6, C11, C12,
C13, m)-methylene protons, 2.0 (C15, t, 3H)-methyl protons, 0.89 ( C14 t, 2H)- methylene protons near
to methyl group.
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 4: Cell viability using MTT cytotoxicity assay was performed for the
cells treated with anacardic acid isolated from CNSE (at a concentration range of 1-12.5µM) in serum
containing DMEM. Each bar represents the mean ± SE of triplicate determinations from three
independent experiments. **P < 0.01, ***P < 0.001 (one-way ANOVA with Dunnett's multiple-
comparison post-test).
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 5. Plot showing relative fluorescence units (RFU) in the absence of (A)
or presence of (B) MMP-2 catalytic core domain.
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 6. Fluorescence-based studies on MMP-2 inhibition by
commercially available anacardic acid. Plot showing comparison of % inhibition of MMP-2 catalytic
core domain in the presence of different concentrations of commercially available saturated anacardic
acid and anacardic acid isolated from CNSE. ***P < 0.001 (one-way ANOVA with Dunnett's multiple-
comparison post-test).
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 7. Confirmation of MMP-2 in the conditioned media. (A) Zymogram
showing molecular weight marker (lane 1-molecular weight marker, lane 2-MMP-2). (B) Zymogram
incubated in developing buffer in the absence of 20mM EDTA (lane 1) or presence of EDTA (lane 2).
(C) Zymogram of conditioned media prepared in SDS-PAGE sample buffer in the absence of 5mM DTT
(lane 1) or in the presence of 5mM DTT (lane 2).
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 8. Effect of different modulators on MMP-2 enzymatic activity.
Representative plot (of the zymogram) showing % MMP-2 inhibition by Anacardic Acid (AA), Salicylic
Acid (SA) and Aspirin. Each bar represents the mean ± SE of triplicate determinations from three
independent experiments. ***P < 0.001 (one-way ANOVA with Tukey’s multiple comparison test).
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 9. HPLC profiles of cardanol (A) Mass Spectrometry profiles of
cardanol showing the masses (m/e) of the three major HPLC molecular peaks, MH+ corresponds to 299
for the triene (1), 301 for the diene (2) and 303 for the monoene (3) forms of cardanol (B) IR spectra of
cardanol and anacardic acid recorded on a Shimadzu IR Affinity -1 in Film(C).
MOL # 79020
Athira Omanakuttan, Jyotsna Nambiar, Rodney M. Harris, Chinchu Bose, N. Pandurangan, Rebu
K.Varghese, Geetha B. Kumar, John A. Tainer, Asoke Banerji, J. Jefferson P. Perry and Bipin G. Nair,
Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix
metalloproteinase-9, Journal of Molecular Pharmacology.
SUPPLEMENTARY FIGURE 10. Fluorescence-based studies on MMP-2 inhibition by cardanol.
Plot showing comparison of % inhibition of MMP-2 catalytic core domain in the presence of different
concentrations of cardanol and anacardic acid isolated from CNSE. ***P < 0.001 (Student’s t-test).